homecourse contentcurrent volumeback volumessubscribecontact usfaq

« Previous IssueNext Issue »
NOTE: This issue is no longer available for CME credit. The AMA's 3-year time limit from when the issue was published has expired. You will be given a score but no credit.

All subscribers to ACOG UPDATE audio CDs will also have free access and ability to download the same program in MP3 format. They can also download a PDF file of the complete transcript with Pre- and Post-test Questions and a List of Supplementary Reading Materials.

Volume 39, Issue 7
Publication date: January 1, 2014
Expiration date: January 1, 2017

Minimally Invasive Treatments for Fibroids
Elizabeth A. Stewart, MD (Moderator)
Professor, Departments of Obstetrics and Gynecology, and Surgery; Chief, Division of Reproductive Endocrinology, Mayo Clinic School of Medicine; Reproductive Endocrinologist, Mayo Clinic, Rochester, Minnesota

Erica E. Marsh, MD, MSCI
Assistant Professor, Divisions of Reproductive Endocrinology and Infertility and Reproductive Biology Research, Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University; Reproductive Endocrinologist, Northwestern Memorial Hospital, Chicago, Illinois

James B. Spies, MD, MPH
Professor and Chair, Department of Radiology, Interventional Radiologist, Georgetown University Hospital, Washington, DC

Learning Objectives
After completing this activity, the physician should be better able to:
1. Describe the health disparities of uterine fibroids for African-American women.
2. Discuss published data on the safety and efficacy of uterine artery embolization (UAE) treatment.
3. List medical therapies and their anticipated effects for uterine fibroids.
4. Enumerate the factors associated with increased risk of uterine sarcomas compared to uterine fibroids.
5. Discuss published data on MRI-guided focused ultrasound surgery (MRgFUS).

Email Address


Forgot my password
Not registered?
Click here to Sign-up
Listen, Learn and Earn